Taysha Gene Therapies, Inc.(TSHA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TSHA Taysha Gene Therapies, Inc.

Post-Mkt 07-23 17:56:58 EDT

5.83

+0.17

+3.00%

盘后5.70

-0.13-2.23%

17:54 EDT

High5.88	Low5.47	Vol2.44M
Open5.51	D1 Closing5.66	Amplitude7.24%
Mkt Cap1.86B	Tradable Cap1.34B	Total Shares319.78M
T/O14.05M	T/O Rate1.07%	Tradable Shares229.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TSHA","market":"US","secType":"STK","nameCN":"Taysha Gene Therapies, Inc.","latestPrice":5.83,"timestamp":1784836800000,"preClose":5.66,"halted":0,"volume":2441975,"hourTrading":{"tag":"盘后","latestPrice":5.7,"preClose":5.83,"latestTime":"17:54 EDT","volume":52213,"amount":304211.891319,"timestamp":1784843669632,"change":-0.13,"changeRate":-0.022298,"amplitude":0.024014},"delay":0,"changeRate":0.030035335689045924,"floatShares":229000000,"shares":319776886,"eps":-0.377498,"marketStatus":"Post-Mkt","change":0.17,"latestTime":"07-23 17:56:58 EDT","open":5.505,"high":5.88,"low":5.47,"amount":14048604.7643925,"amplitude":0.072438,"askPrice":5.95,"askSize":13,"bidPrice":5.29,"bidSize":15,"shortable":3,"etf":0,"ttmEps":-0.377498,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1784851200000},"marketStatusCode":4,"adr":0,"listingDate":1600920000000,"exchange":"NASDAQ","adjPreClose":5.66,"preHourTrading":{"tag":"盘前","latestPrice":5.51,"preClose":5.66,"latestTime":"09:29 EDT","volume":379,"amount":2106.1101252,"timestamp":1784813399999,"change":-0.15,"changeRate":-0.026502,"amplitude":0.102473},"postHourTrading":{"tag":"盘后","latestPrice":5.7,"preClose":5.83,"latestTime":"17:54 EDT","volume":52213,"amount":304211.891319,"timestamp":1784843669632,"change":-0.13,"changeRate":-0.022298,"amplitude":0.024014},"volumeRatio":0.99557,"impliedVol":1.0071,"impliedVolPercentile":0.5657},"requestUrl":"/m/hq/s/TSHA","defaultTab":"news","newsList":[{"id":"2653127064","title":"Taysha Gene Therapies is Maintained at Buy by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2653127064","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653127064?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:54","pubTimestamp":1784638440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TSHA/analyst-ratings(END) Dow Jones NewswiresJuly 21, 2026 08:54 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651514395","title":"Taysha Gene Therapies falls -11.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651514395","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651514395?lang=en_us&edition=fundamental","pubTime":"2026-07-14 00:05","pubTimestamp":1783958718,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies (TSHA) is down -11.0%, or -70c to $5.64. Published first on TheFly – the ultimate source for real-time, market-moving breakin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/taysha-gene-therapies-falls-11-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/taysha-gene-therapies-falls-11-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TSHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650158893","title":"Taysha Gene Therapies President, Head of R&D Sukumar Nagendran Disposes of 200,000 Common Shares for $1.25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2650158893","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650158893?lang=en_us&edition=fundamental","pubTime":"2026-07-11 06:55","pubTimestamp":1783724115,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies President, Head of R&D Sukumar Nagendran disposes of 200,000 common shares for $1.25 millionTaysha Gene Therapies President and Head of R&D Sukumar Nagendran sold 200,000 common ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDLXYJkG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Taysha Gene Therapies President, Head of R&D Sukumar Nagendran Disposes of 200,000 Common Shares for $1.25 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650123138","title":"Taysha Gene Therapies (TSHA) Could Be 49% Below Fair Value After Russell Index Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2650123138","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650123138?lang=en_us&edition=fundamental","pubTime":"2026-07-10 20:31","pubTimestamp":1783686689,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies (TSHA) was recently removed from several Russell indexes, including the Russell 3000E and Russell Microcap families, a change that can influence trading flows as passive funds rebalance.\nSee our latest analysis for Taysha Gene Therapies.\nDespite the index removals, Taysha Gene Therapies’ recent share price performance has been strong, with a 30 day share price return of 22.57% and a 90 day share price return of 46.33%, while the 1 year total shareholder return sits at a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tsha/taysha-gene-therapies/news/taysha-gene-therapies-tsha-could-be-49-below-fair-value-afte","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tsha/taysha-gene-therapies/news/taysha-gene-therapies-tsha-could-be-49-below-fair-value-afte","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","TSHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648875688","title":"Taysha Gene Therapies Price Target Maintained with a $11.00/share by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2648875688","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648875688?lang=en_us&edition=fundamental","pubTime":"2026-07-02 21:06","pubTimestamp":1782997560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TSHA/analyst-ratings(END) Dow Jones NewswiresJuly 02, 2026 09:06 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648151007","title":"Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Taysha Gene Therapies (TSHA) and Zymeworks (ZYME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648151007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648151007?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:50","pubTimestamp":1782906610,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nurix Therapeutics (NRIX), Taysha Gene Therapies (TS...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nurix-therapeutics-nrix-taysha-gene-therapies-tsha-and-zymeworks-zyme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nurix-therapeutics-nrix-taysha-gene-therapies-tsha-and-zymeworks-zyme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0029874061.USD","NRIX","BK4585","ZYME","XLV","XBI","LU0128526141.USD","LABU","TSHA","BK4137","BK4588","HCSG","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647553113","title":"Taysha Gene Therapies is Maintained at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2647553113","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647553113?lang=en_us&edition=fundamental","pubTime":"2026-06-30 20:01","pubTimestamp":1782820860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TSHA/analyst-ratings(END) Dow Jones NewswiresJune 30, 2026 08:01 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647558396","title":"Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647558396","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647558396?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:20","pubTimestamp":1782818417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-heartflow-inc-htfl-taysha-gene-therapies-tsha-and-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-heartflow-inc-htfl-taysha-gene-therapies-tsha-and-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","HTFL","ABVX","BK4137","AAVXF","LABU","BK4581","LU0029874061.USD","BK4585","XLV","XBI","TSHA","BK4139","BK4167","BK4588","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647377587","title":"Taysha Gene Therapies Posts Reveal Part a Phase 1/2 Tsha-102 Rett Syndrome Trial Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2647377587","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647377587?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:56","pubTimestamp":1782741377,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies posts REVEAL Part A Phase 1/2 TSHA-102 Rett syndrome trial presentationTaysha Gene Therapies published safety and efficacy results from REVEAL Part A Phase 1/2 trial of TSHA-102 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL7b1QWw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646389815","title":"Taysha Gene Therapies Announces Major Equity Financing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2646389815","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646389815?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:50","pubTimestamp":1782420616,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies ( ($TSHA) ) just unveiled an update. On June 24, 2026, Taysha Gene Therapies, Inc. entered into an underwriting agreement wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/taysha-gene-therapies-announces-major-equity-financing-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/taysha-gene-therapies-announces-major-equity-financing-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","EQR","BK4215","BK4585","TSHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646038532","title":"Taysha Gene Therapies Announces Multiple Presentations Highlighting Its Tsha-102 Clinical Program at the 2026 Irsf Rett Syndrome Scientific Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2646038532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646038532?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:01","pubTimestamp":1782417696,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUA7ZXD5J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TSHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646338530","title":"Taysha Gene Therapies to Present Reveal Phase 1/2 Data for Rett Gene Therapy Tsha-102 at 2026 IRSF Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2646338530","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646338530?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:01","pubTimestamp":1782417684,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies to present REVEAL Phase 1/2 data for Rett gene therapy TSHA-102 at 2026 IRSF meetingTaysha Gene Therapies flagged new updates for TSHA-102 in Rett syndrome ahead of the 2026 IRSF","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL98HFBj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU0314104364.USD","BK4139","IE00BGHQF748.EUR","BK4585","LU2095319765.USD","SG9999014021.USD","SG9999014005.SGD","TSHA","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BK4588","BK4112","NDAQ","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646304385","title":"Taysha Gene Therapies management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2646304385","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646304385?lang=en_us&edition=fundamental","pubTime":"2026-06-26 03:50","pubTimestamp":1782417009,"startTime":"0","endTime":"0","summary":"Meeting to be held in Minneapolis on June 30 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/taysha-gene-therapies-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/taysha-gene-therapies-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TSHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646887783","title":"Taysha Gene Therapies Down over 11%, on Pace for Largest Percent Decrease Since May 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2646887783","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646887783?lang=en_us&edition=fundamental","pubTime":"2026-06-26 03:06","pubTimestamp":1782414360,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies, Inc.  is currently at $6.16, down $0.78 or 11.17%--Would be lowest close since June 16, 2026, when it closed at $5.85--On pace for largest percent decrease since May 6, 2025, when it fell 18.7%--Snaps a five day winning streak--Up 5.03% month-to-date; on pace for best month since April 2026, when it rose 42.95%--Up 12.09% year-to-date--Down 80.58% from its all-time closing high of $31.75 on Jan. 20, 2021--Up 155.81% from 52 weeks ago , when it closed at $2.41--Down 11.68% from its 52-week closing high of $6.98 on May 6, 2026--Up 166.88% from its 52-week closing low of $2.31 on June 30, 2025--Traded as low as $6.06; lowest intraday level since June 17, 2026, when it hit $5.90--Down 12.68% at today's intraday low; largest intraday percent decrease since Nov. 3, 2025, when it fell as much as 19.96%All data as of 3:03:42 PM ETSource: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 25, 2026 15:06 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TSHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646803035","title":"Sector Update: Health Care Stocks Mixed Pre-Bell Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2646803035","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646803035?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:16","pubTimestamp":1782393378,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Thursday, with the State Street Health Care Select Sector SPDR ETF  retreating by 0.2% and the iShares Biotechnology ETF  advancing 0.1%.Bio-Techne  stock rose more than 20% premarket after the company signed a definitive agreement to be acquired by Germany's Merck KGaA for $73 a share, representing an enterprise value of $11.3 billion.RadNet's  shares were down 1.8% pre-bell after rising 3.5% at the prior close. The company's DeepHealth unit said it received FDA 510 clearance for two breast imaging AI tools, including a breast arterial calcification assessment and prior exam integration for its ProFound Pro platform.Taysha Gene Therapies  stock lost more than 9% after the company priced an underwritten public offering of 32.5 million shares at $6.00 each and pre-funded warrants to purchase 833,333 shares at $5.999 each.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","BK4585","BK4139","IE00B64QTZ34.USD","XLV","LU2237957902.USD","TSHA","BK4121","LU2237957811.SGD","LU2065731478.USD","BK4581","XBI","BK4196","TECH.AU","RDNT","TECH","IE00B19Z6F94.USD","IE0034390439.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646835826","title":"Taysha Gene Therapies 32.5M share Spot Secondary priced at $6.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2646835826","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646835826?lang=en_us&edition=fundamental","pubTime":"2026-06-25 11:30","pubTimestamp":1782358210,"startTime":"0","endTime":"0","summary":"The deal priced below last closing price of $6.94. Baird is acting as sole book running manager for the offering. Published first on TheFly – the u...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/taysha-gene-therapies-32-5m-share-spot-secondary-priced-at-6-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/taysha-gene-therapies-32-5m-share-spot-secondary-priced-at-6-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TSHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646508823","title":"Taysha Gene Therapies - Prices Offering of 32.5 Mln Shares at $6 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2646508823","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646508823?lang=en_us&edition=fundamental","pubTime":"2026-06-25 10:33","pubTimestamp":1782354813,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUA1QNS23:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TSHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646849263","title":"Taysha Gene Therapies Inc: Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2646849263","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646849263?lang=en_us&edition=fundamental","pubTime":"2026-06-25 05:27","pubTimestamp":1782336462,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42W0GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TSHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646405845","title":"Taysha Gene Therapies announces $200M common stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2646405845","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646405845?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:05","pubTimestamp":1782331537,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies (TSHA) announced that it has commenced an underwritten public offering of $200M shares of its common stock and, in lieu of co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/taysha-gene-therapies-announces-200m-common-stock-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/taysha-gene-therapies-announces-200m-common-stock-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TSHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646843095","title":"Taysha Gene Therapies Launches USD 200 Million Common Stock, Pre-funded Warrants Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2646843095","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646843095?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:01","pubTimestamp":1782331302,"startTime":"0","endTime":"0","summary":"Taysha Gene Therapies launches USD 200 million common stock, pre-funded warrants offeringTaysha Gene Therapies launched an underwritten public offering of USD 200 million of common stock.Deal includes","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDLbMyz5j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061475181.USD","LU1868837300.USD","NDAQ","PIPR","IE00BN0W2W23.USD","LU2471134796.USD","LU2095319765.USD","LU2237443978.SGD","LU1668664300.SGD","IE00B64PRP62.GBP","LU2237443622.USD","LU2471134879.HKD","GSX","BK4552","LU0251131958.USD","LU0345770308.USD","LU1868837136.USD","LU2265009873.SGD","IE0034235188.USD","LU0345770993.USD","LU0106831901.USD","LU2471134952.CNY","IE00B19Z3581.USD","BK4516","LU1868836914.USD","IE00BFXG1179.USD","LU0868494708.USD","LU1791807156.HKD","LU1894683264.USD","IE00BGHQF748.EUR","IE00B19Z3B42.SGD","LU2210149790.SGD","TSHA","IE0002270589.USD","LU2750360997.AUD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU0251142724.SGD","BK4504","LU1868836757.USD","BK4550","LU2237443549.SGD","LU0096364046.USD","LU1868836591.USD","BK4585","LU2237443465.HKD","SG9999014039.USD","LU0314104364.USD","LU2210150020.SGD","IE0004091025.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tayshagtx.com","stockEarnings":[{"period":"1week","weight":-0.0856},{"period":"1month","weight":-0.1332},{"period":"3month","weight":-0.1156},{"period":"6month","weight":0.2146},{"period":"1year","weight":1.1521},{"period":"ytd","weight":0.0291}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0041},{"period":"3month","weight":0.055},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.1885},{"period":"ytd","weight":0.096}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. The company was incorporated in 2019 and is based in Dallas, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.177745},{"month":2,"riseRate":0.5,"avgChangeRate":0.091899},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.104956},{"month":4,"riseRate":0.5,"avgChangeRate":0.079391},{"month":5,"riseRate":0.333333,"avgChangeRate":0.032889},{"month":6,"riseRate":0.333333,"avgChangeRate":0.002069},{"month":7,"riseRate":0.5,"avgChangeRate":-0.012056},{"month":8,"riseRate":0.8,"avgChangeRate":0.75256},{"month":9,"riseRate":0.2,"avgChangeRate":-0.089587},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.04036},{"month":11,"riseRate":0.5,"avgChangeRate":0.137875},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.034429}],"exchange":"NASDAQ","name":"Taysha Gene Therapies, Inc.","nameEN":"Taysha Gene Therapies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Taysha Gene Therapies, Inc.(TSHA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Taysha Gene Therapies, Inc.(TSHA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Taysha Gene Therapies, Inc.,TSHA,Taysha Gene Therapies, Inc.股票,Taysha Gene Therapies, Inc.股票老虎,Taysha Gene Therapies, Inc.股票老虎国际,Taysha Gene Therapies, Inc.行情,Taysha Gene Therapies, Inc.股票行情,Taysha Gene Therapies, Inc.股价,Taysha Gene Therapies, Inc.股市,Taysha Gene Therapies, Inc.股票价格,Taysha Gene Therapies, Inc.股票交易,Taysha Gene Therapies, Inc.股票购买,Taysha Gene Therapies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Taysha Gene Therapies, Inc.(TSHA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Taysha Gene Therapies, Inc.(TSHA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}